Revised SPC: Triumeq (abacavir sulfate, dolutegravir sodium, lamivudine) tablets
SPC notes a new contraindication in relation to co-administration with medicinal products with narrow therapeutic windows, that are substrates of OCT-2, e.g. fampridine.
Source:
electronic Medicines compendium